Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers in rats

被引：0

作者：

Konturek, SJ ^{[1
]}

Sliwowski, Z ^{[1
]}

Brzozowski, T ^{[1
]}

Konturek, PC ^{[1
]}

Pajdo, R ^{[1
]}

Drozdowicz, D ^{[1
]}

Stachura, J ^{[1
]}

Hahn, EG ^{[1
]}

机构：

[1] Univ Cracow, Sch Med, Krakow, Poland

来源：

GASTROENTEROLOGY | 1999年 / 116卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

G0959

引用

页码：A220 / A220

页数：1

共 50 条

[21] Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial~1
Lars BOHLIN
Acta Pharmacologica Sinica, 2005, (08) : 926 - 933
[22] Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors
Kulkarni, SK
Jain, NK
Singh, A
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2000, 22 (05): : 291 - 298
[23] Roles of COX-1 and COX-2 inhibition in NSAID-induced gastric damage in rats: Relation to gastric hypermotility response
Takeuchi, K
Tanaka, A
Araki, H
Komoike, Y
Takeeda, M
GASTROENTEROLOGY, 2001, 120 (05) : A594 - A594
[24] NSAID inhibition of RGM1 gastric monolayer wound re-epithelialization: comparison of selective Cox-2 versus non-selective Cox inhibitors
Giap, AQ
Tarnawski, A
Hoa, NT
Akotia, V
Ma, TY
LIFE SCIENCES, 2002, 70 (25) : 3029 - 3037
[25] COX-1 and COX-2 inhibitors
Hawkey, CJ
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2001, 15 (05) : 801 - 820
[26] Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia
Fosslien, E
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2000, 37 (05) : 431 - 502
[27] Novel selective cyclooxygenase-(COX)-2 inhibitors of the diarylethersulfonamide type show greater inhibition on human COX-2 than on murine COX-2
Berg, J
Fellier, H
Hartmann, M
Kremminger, P
Blaschke, H
Christoph, T
Bodenteich, A
Rovensky, F
Stimmeder, D
Towart, R
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R716 - R716
[28] Uptake of COX-2 selective inhibitors and influence on NSAID prescribing in Northern Ireland
Girvin, B
Rafferty, T
Stevenson, MR
Johnston, GD
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (03) : 153 - 157
[29] Selective cyclooxygenase-2 (COX-2) inhibitors and breast cancer risk
Ashok, Varun
Dash, Chiranjeev
Rohan, Thomas E.
Sprafka, J. Michael
Terry, Paul D.
BREAST, 2011, 20 (01): : 66 - 70
[30] Nonsteroidal drug (NSAID)-induced fall in HT-29 cell viability correlates with potency to inhibit cyclooxygenase (COX) 1: Use of COX-2 selective inhibitors
McCartney, SA
Vojnovic, I
Farthing, MJG
Warner, TD
GASTROENTEROLOGY, 1998, 114 (04) : A641 - A641

← 1 2 3 4 5 →